Suicide Gene Therapy

Bystander Transfer of GCV Nucleotides Enhance Killing

Published in Cancer Weekly, March 8th, 1999

The efficiency of transfer of highly potent Ganciclovir (GCV) nucleotides may be responsible for the efficacy of bystander-mediated killing in herpes simplex virus (HSV) thymidine kinase (TK)/GCV suicide gene therapy.

In order to optimize HSV-TK/GCV gene therapy, more detailed studies on how the bystander effect works are needed. It is also important that the cells being studied are developed from the same parental cell line.

Laura Z. Rubsam and colleagues from the University of Michigan evaluated GCV cytotoxicity and nucleotide transfer in HSV-TK-expressing and bystander cells generated from a human glioblastoma cell line ("Cytotoxicity and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1999-03-08)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry